Sparc
-
{
- All
- News
-
Government Invites Proposals For High-Impact Global Research, Check Details
- Saturday July 12, 2025
- Education | Edited by Rahul Kumar
SPARC aims to transform India's higher education research landscape by promoting international collaboration in solving national and global challenges.
-
www.ndtv.com/education
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
- Friday December 8, 2023
- Author: Press Trust of India
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
www.ndtvprofit.com
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
- Friday December 8, 2023
- Author: Press Trust of India
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
www.ndtvprofit.com
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
- Thursday December 7, 2023
- Author: Press Trust of India
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
www.ndtvprofit.com
-
ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20
- Monday October 19, 2020
- Author: ICICI Securities
ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20
-
www.ndtvprofit.com
-
IIT Madras, German Researchers Collaborate To Develop New Green Energy Materials
- Thursday June 25, 2020
- Education | Edited by Anisha Kumari
IIT Madras Researchers have collaborated with German Researchers to develop new materials for Green Energy Solutions.
-
www.ndtv.com/education
-
Research Work Under IMPRESS, SPARC Schemes To Begin In January 2019: HRD Minister
- Thursday October 25, 2018
- Education | Press Trust of India
"A country achieves prosperity on a sustainable basis only through innovation which can happen only by good research and which is currently a major focus area of the government," he said while addressing a press conference.
-
www.ndtv.com/education
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
- Thursday December 22, 2016
- Press Trust of India
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
www.ndtvprofit.com
-
Sun Pharma Advanced Research Q1 Loss Widens To Rs 36 Crore
- Friday July 29, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported widening of standalone net loss to Rs 36.41 crore for the first quarter that ended on June 30.
-
www.ndtvprofit.com
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
- Monday July 18, 2016
- Press Trust of India
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
www.ndtvprofit.com
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
- Monday July 18, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
www.ndtvprofit.com
-
SPARC Q4 Net Loss Widens To Rs 9.6 Crore
- Friday May 6, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
-
www.ndtvprofit.com
-
SPARC Gets Sebi Nod to Mop up Rs 250 Crore Via Rights Issue
- Tuesday January 26, 2016
- Press Trust of India
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) has received markets regulator Sebi's approval to raise up to Rs 250 crore through a rights issue.
-
www.ndtvprofit.com
-
Government Invites Proposals For High-Impact Global Research, Check Details
- Saturday July 12, 2025
- Education | Edited by Rahul Kumar
SPARC aims to transform India's higher education research landscape by promoting international collaboration in solving national and global challenges.
-
www.ndtv.com/education
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
- Friday December 8, 2023
- Author: Press Trust of India
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
www.ndtvprofit.com
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
- Friday December 8, 2023
- Author: Press Trust of India
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
www.ndtvprofit.com
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
- Thursday December 7, 2023
- Author: Press Trust of India
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
www.ndtvprofit.com
-
ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20
- Monday October 19, 2020
- Author: ICICI Securities
ICICI Securities: India’s Aggregate R&D Spend By Listed Companies Remains Low At Rs 360 Billion In FY20
-
www.ndtvprofit.com
-
IIT Madras, German Researchers Collaborate To Develop New Green Energy Materials
- Thursday June 25, 2020
- Education | Edited by Anisha Kumari
IIT Madras Researchers have collaborated with German Researchers to develop new materials for Green Energy Solutions.
-
www.ndtv.com/education
-
Research Work Under IMPRESS, SPARC Schemes To Begin In January 2019: HRD Minister
- Thursday October 25, 2018
- Education | Press Trust of India
"A country achieves prosperity on a sustainable basis only through innovation which can happen only by good research and which is currently a major focus area of the government," he said while addressing a press conference.
-
www.ndtv.com/education
-
US Drug Regulator Subjects SPARC Xelpros Nod To 'Satisfactory Resolution'
- Thursday December 22, 2016
- Press Trust of India
Sun Pharma Advanced Research Company today said the US health regulator has not approved its new drug application for Xelpros, a preservative-free eye drop.
-
www.ndtvprofit.com
-
Sun Pharma Advanced Research Q1 Loss Widens To Rs 36 Crore
- Friday July 29, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported widening of standalone net loss to Rs 36.41 crore for the first quarter that ended on June 30.
-
www.ndtvprofit.com
-
SPARC Shares Surge Nearly 8% On Licensing Pact With Sun Pharma
- Monday July 18, 2016
- Press Trust of India
Shares of Sun Pharma Advanced Research Company (SPARC) surged 8 per cent as the company and parent Sun Pharma entered into a licensing deal for Elepsia tablets in the US for upfront payment of $10 million.
-
www.ndtvprofit.com
-
SPARC and Sun Pharma Ink Licensing Pact For Epilepsy Drug
- Monday July 18, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
-
www.ndtvprofit.com
-
SPARC Q4 Net Loss Widens To Rs 9.6 Crore
- Friday May 6, 2016
- Press Trust of India
Sun Pharma Advanced Research Company (SPARC), the pharma research and drug discovery arm of Sun Pharma, on Friday reported a slight increase in its stand-alone net loss at Rs 9.58 crore for the quarter to March 2016.
-
www.ndtvprofit.com
-
SPARC Gets Sebi Nod to Mop up Rs 250 Crore Via Rights Issue
- Tuesday January 26, 2016
- Press Trust of India
Drug discovery firm Sun Pharma Advanced Research Company (SPARC) has received markets regulator Sebi's approval to raise up to Rs 250 crore through a rights issue.
-
www.ndtvprofit.com